|2.||Alzheimer Disease (Alzheimer's Disease)
|5.||Frontotemporal Lobar Degeneration (Semantic Dementia)
|1.||Miller, Bruce L: 2 articles (08/2011 - 07/2009)|
|2.||Boxer, Adam L: 2 articles (08/2011 - 07/2009)|
|3.||Wolk, David A: 1 article (12/2013)|
|4.||Williams, Guy B: 1 article (07/2013)|
|5.||Patterson, Karalyn: 1 article (07/2013)|
|6.||Acosta-Cabronero, Julio: 1 article (07/2013)|
|7.||Diaz-de-Grenu, Lara Z: 1 article (07/2013)|
|8.||Nestor, Peter J: 1 article (07/2013)|
|9.||Sajjadi, Seyed A: 1 article (07/2013)|
|10.||Paolini, Susy: 1 article (01/2013)|
|1.||tranilast (N 5')IBA
07/01/2013 - "At 1 year follow-up, all participants with non-fluent primary progressive aphasia had evolved either corticobasal degeneration (n = 5) or progressive supranuclear palsy (n = 4). "
08/01/2011 - "CBD was associated with 4 clinical syndromes: progressive nonfluent aphasia (n = 5), behavioral variant frontotemporal dementia (n = 5), executive-motor (n = 7), and posterior cortical atrophy (n = 1). "
07/01/2011 - "Here we undertook a systematic study of nonverbal sound processing in patient groups with canonical dementia syndromes comprising clinically diagnosed typical amnestic Alzheimer's disease (AD; n=21), progressive nonfluent aphasia (PNFA; n=5), logopenic progressive aphasia (LPA; n=7) and aphasia in association with a progranulin gene mutation (GAA; n=1), and in healthy age-matched controls (n=20). "
|2.||tau Proteins (tau Protein)IBA
01/01/2011 - "The V363I mutation of the microtubule-associated protein tau gene has previously been associated with a case of primary progressive nonfluent aphasia with variable penetrance. "
08/01/2007 - "Reported here is a new missense mutation V363I in exon 12 of the microtubule-associated protein tau (MAPT) gene associated with progressive nonfluent aphasia, with onset at the age of 69 years in a woman. "
|3.||Sodium Glutamate (Accent)IBA
|4.||Memantine (Namenda)FDA Link
|5.||Glucose (Dextrose)FDA LinkGeneric
|6.||DNA (Deoxyribonucleic Acid)IBA
|7.||Amyloid (Amyloid Fibrils)IBA
12/01/2013 - "As each of these syndromes is variably associated with non-AD dementia and clinically overlaps with other presentations more commonly associated with different causes of neurodegeneration (e.g., progressive nonfluent aphasia), the use of amyloid imaging for detection of the molecular pathologic features of AD is of significant clinical value. "
|8.||N-acetylaspartate (N-acetyl aspartate)IBA